TH588 is nudix hydrolase family inhibitor that correctly and selectively engages and inhibits the MTH1(IC50: 5 nM) in cells. Also, this process could inactivate the mutation of residual viral DNA. They concluded that CRISPR/Cas9 systems could serve as productive applications for disrupting the cccDNA pool in chronically-contaminated HBV individuals. As https://ax-1583658901.diowebhost.com/83199771/the-best-side-of-deoxyshikonin